Search results for MEK1 antibody

MEK1 antibody [1C1], Genetex, GTX84168

Anti-MEK1 antibody, Abcam, AB109556

MEK1 + MEK2 antibody, Genetex, GTX52369

MEK1 + MEK2 antibody, Genetex, GTX52370

MEK1 + MEK2 antibody, Genetex, GTX121942

MEK1 + MEK2 antibody [N2C2], Internal, Genetex, GTX121943

Anti-MEK1 antibody [E342], Abcam, AB32091

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-MEK1 antibody [OTI4E1], Abcam, AB139343

The clone number has been updated from 4E1 to OTI4E1, both clone numbers name the same clone.

Anti-MEK1 antibody [Y77], Abcam, AB32576

Species reactivity Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

PE Anti-MEK1 antibody [E342], Abcam, AB210618

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents .